Timothy F. Feltes, MD

Timothy F. Feltes, MD, FACC, is Chief of Pediatric Cardiology, Cardiac Intensivist and Co-Director of The Heart Center at Nationwide Children's Hospital. He is also Chief of Pediatric Cardiology and Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Feltes received his pediatric training at Emory University (Atlanta) and his pediatric cardiology training at Baylor College of Medicine (Texas Children’s Hospital, Houston). He was the first Director of the Cardiac Intensive Care at Texas Children’s Hospital (1991-2001). He is the recipient of the Pediatric Cardiac Intensive Care Society Career Achievement Award (2010), the recipient of the Andy Paxton Endowed Chair in Cardiology and is serving as the National Chairman of the Cardiology Sub-board of the American Board of Pediatrics (2011-12). Dr. Feltes is board certified in Pediatrics and Pediatric Cardiology.

Gender:

• Male

Languages Spoken:

• English

Research Center:

• Hospital-Based Research Faculty

Medical School

• Medical College of Ohio at Toledo
  Date Completed: 06/05/1980

Internship

• Emory University Hospital
  Date Completed: 06/30/1981

Residency

• Emory University Hospital
  Date Completed: 06/30/1983

Fellowship

• Texas Children's Hospital
  Date Completed: 06/30/1986

Department:

• Pediatrics

Section:

• Cardiology

Speciality:

• Pediatric Cardiology
  
• Pediatrics
  

Date of Appointment at Nationwide Children’s Hospital:

• 08/10/2001

• Feltes TF, Sondheimer HM, Tulloh RMR, Harris BS, Kensen KM, Losonsky GA, Griffin MP. 2011. A ranodomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically signficant congenital heart disease.  Pediatric Research.
• Feltes TF, Bacha E, Beekman RH, Cheatham JP, Feinstein JA, Gomes A, Hijazi ZM, Ing FF, deMoor MD, MOrrow WR, Mullins CE, Taubert KA, Zahn EM. 2011. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement by the american heart assoiciation.  Circulation.
• Minich LL, Atz AM, Colan SD et al. 2010. Partial and transitional atrioventricular septal defects outcomes.  Ann Thorac Surg.
• Felts TF, Simoes E. 2010. Palivizumab prophylaxis in haemodynamically significant congenital hear disease.  Arch Dis Child. Vol. 90, no. January: 875-877.
• Margossian R, Schwartz ML, Prakash A, et al. 2009. Comparison of echocardiographic and cardiac magnetic resonance imagin measurements.  Am J Cardiology. Vol. 104, no. August. (January): 419-428.
• Lambert LM, Minich LL, Newberger JW et al. 2009. Paretn-versus child-reported.  Pediatrics. Vol. 124, no. November. (January): e942-e949.
• Crumb SR, Cook SC, Cheatham JP, Glantowicz M, Feltes TF et al. 2009. QWuality Outcomes of ACHD patients undergoing cardiovascular procedures and hospital admissions in a free-standing children's hospital.  Int J Cardiol. Vol. 7, no. August. (January).
• Hsu DT, Mital S, ravishankar C, et al. 2009. Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle.  Am Heart Journal. Vol. 157, no. Jan. (January): 37-45.
• Timothy F Feltes. 2008. US Respiratory Diseases 2007: State of RSV prophylaxis in congenital heart disease patients and the questions that linger. London: Touch Briefings.
• Blaufox AD, Sleeper LA, Bradley DJ, et al. 2008. Functional status, heart rate, and rhythm abnormalities in 521 Fontan patients 6 to 18 years of age.  J Thorac Cardiovasc Surg. Vol. 136, no. Jluy. (January): 100-107.
• TF Feltes, WA Luce, JA Bauer. 2008. Proceedings of the 13th World Congress of Heart Disease: The Neonatal Inflammatory Response. Balogna: Medimond, Inc..
• Ohye RG, Gaynor JW, Ghanayem NS, et al. 2008. Design and rationale of a randomized tiral comapring the Blalock-Taussig and right ventricle-pulmonary artery.  J Thorac Cardiovasc Surg. Vol. 136, no. Oct. (January): 968-975.
• Feltes TF, Sondheimer HM. 2007. Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease.  Expert Opinion on Biological Therapy. Vol. 7, no. 9. (January): 1471-1480.
• Friedman AK, Fogel MA, Stephens P, Hellinger JC, Nykanen DG, Tweddell J, Felts TF, Rome JJ. 2007. Identification, imaging, functional assessment and management of congenital coronary arterial abnomalities in children.  Cardiol Young. Vol. Supplement 2, no. January: 56-67.
• Luce WA, Joshi MS, Hoffman TM, Feltes TF, Bauer JA. 2007. Immune mechanisms in pediatric cardiovascular disease. In Immune Dysfunction and Immunotherapy in Heart Disease. Edited by Watson RR, Larson D. Boston, MA: Blackwell Publishing.
• Luce WA, Joshi MS, Hoffman T, Feltes TF, Bauer JA. 2007. Immune mechanisms in pediatric cardiovascular disease. In Immune Dysfunction and Immunotherapy in Heart Disease. Edited by Watson, Larson. New Delhi: Blackwell Publishing.
• Hoffman TM, Taeed R, Niles JP, McMillan MA, Perkins LA, Feltes TF. 2007. Parental factors impacting the enrollment of children in cardiac critical care clinical trials.  Pediatric Cardiology. Vol. 28, no. January: 167-171.
• Fischer A, Long F, Feltes TF. 2007. Hepatic necrosis following repair of totally anomalous pulmonary venous connection.  Cardiology in the Young. Vol. 17, no. 4. (January): 435-437.
• Dyke PC 2nd, Yates AR, Cua CL, Hoffman TM, Hayes J, Feltes TF, Springer MA, Taeed R. 2007. Increased calcium supplementation is associated with morbidity and mortality in the infant postoperative cardiac patient.  Pediatric Critical Care Medicine. Vol. 8, no. 3. (January): 254-257.
• Yates AR, Dyke PC, Taeed R, Hoffman TM, Hayes J, Feltes TF, Cua CL. 2006. Hyperglycemia is a marker for poor outcome in teh postoperative pediatric cardiac patients.  Pediatr Crit Care Med. Vol. 7, no. January: 351-355.
• Feltes TF, Hodinka RL, Paridon SM, Wernovsky G, Sondheimer. 2006. The current state of infection with respiratory syncytial virus in the setting of congenital heart cardiac malformations.  Cardiol Young. Vol. Suppl 3, no. January: 136-143.
• Tulloh Rm, Feltes TF. 2005. The European Forum for Clinical Management: prophylaxis againt the respiratory syncytial virus in infants and young children with congenital cardiac disase.  Cardiol Young. Vol. 15, no. January: 274-278.
• Cua CL, Thiagariajan RR,...Feltes TF. 2005. Improved interstage mortality with teh modified Norwood procedure: a meta-analysis.  Ann Thorac Surg. Vol. 80, no. January: 44-49.
• Cannon BC, Feltes TF, Fraley JK, Grifka RG, Riddle EM, Kovalchin JP. 2005. NItric oxide in the evaluation of congenital heart disease with pulmonary hypertension: factors related to nitric oxide response.  Pediatr Cardiol. Vol. 26, no. January: 565-569.
• Bonnet d, Shmaltz AA, Felte TF. 2005. Infection by the respiratory syncytial virus in infants and young children at risk.  Cardiol Young. Vol. 15, no. January: 256-265.
• Feltes TF, Groothuis JR. 2005. Acute and long-term effects of infection by the respiratory syncytial virus in childre with congenital cardiac maformations.  Cardiol Young. Vol. 15, no. January: 266-273.

• Listed, Best Doctors in America
• Listed, Docs Rate Docs, Columbus Dispatch and WBNS-10 TV Poll